DOSSIER · 13F Holders · Q1 2026
APELLIS PHARMACEUTICALS INC
2 institutions still hold APELLIS PHARMACEUTICALS INC as of Q1 2026. Tracked across SEC 13F-HR filings, with insider and 13D/G activity surfaced alongside.
CUSIP 03753U906·2 13F holders·last filed Mar 31, 2026
AI Holders Summary · Q1 2026
2 institutions reported APELLIS PHARMACEUTICALS INC in Q1 2026. SG Americas Securities, LLC leads at 100.0% of the visible book.
Top holders
Sorted by position value. Source: SEC EDGAR 13F-HR filings.